Pfizer Stock: Is PFE Underperforming the Healthcare Sector?

With a market cap of $154.3 billion, Pfizer Inc. (PFE) is a global biopharmaceutical company that discovers, develops, manufactures, and markets medicines and vaccines across a wide range of therapeutic areas in the United States and internationally. It also engages in contract manufacturing and strategic collaborations with partners including Bristol-Myers Squibb, Astellas, BioNTech, and Boltz, PBC to advance innovative drug development. Companies valued more than $10 billion are generally classified as ...